---
figid: PMC3219027__cc10283-8
figtitle: Putative mechanism of dexmedetomidine (Dex) renoprotection
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3219027
filename: cc10283-8.jpg
figlink: /pmc/articles/PMC3219027/figure/F8/
number: F8
caption: Putative mechanism of dexmedetomidine (Dex) renoprotection. Dexmedetomidine
  stimulates the α2 adrenoceptor (α2) to induce phosphoinositol-3-kinase (PI3K) phosphorylation
  of Akt (pAKT) and activation of the downstream cell survival signaling to block
  ischemia induced injury. Ischemia is denoted by the "flash" symbol. Improved cellular
  survival leads to reduced release of the damage-associated molecular pattern High-mobility
  group protein B1 (HMGB1). Reduced HMGB1 decreases the inflammatory drive that both
  increases Toll-like receptor 4 (TLR4) expression and activates the detrimental effect
  of TLR4 signaling in renal ischemia. Co-receptors for HMGB1 include TLRs and Interleukin-1
  (IL-1) receptor; when HMGB1 binds to the ligand (for example, lipopolysaccharide
  or IL-1) this augments subsequent proinflammatory signaling. Therefore, dexmedetomidine
  acts proximally in the pathway (at the cytoprotective level) to prevent the elaboration
  of renal ischemic injury. 'Lightening bolt' denotes ischemia. 'Square' denotes HMGB1
  co-receptor.
papertitle: Dexmedetomidine provides renoprotection against ischemia-reperfusion injury
  in mice.
reftext: Jianteng Gu, et al. Crit Care. 2011;15(3):R153-R153.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8592515
figid_alias: PMC3219027__F8
figtype: Figure
redirect_from: /figures/PMC3219027__F8
ndex: c587981a-dea1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3219027__cc10283-8.html
  '@type': Dataset
  description: Putative mechanism of dexmedetomidine (Dex) renoprotection. Dexmedetomidine
    stimulates the α2 adrenoceptor (α2) to induce phosphoinositol-3-kinase (PI3K)
    phosphorylation of Akt (pAKT) and activation of the downstream cell survival signaling
    to block ischemia induced injury. Ischemia is denoted by the "flash" symbol. Improved
    cellular survival leads to reduced release of the damage-associated molecular
    pattern High-mobility group protein B1 (HMGB1). Reduced HMGB1 decreases the inflammatory
    drive that both increases Toll-like receptor 4 (TLR4) expression and activates
    the detrimental effect of TLR4 signaling in renal ischemia. Co-receptors for HMGB1
    include TLRs and Interleukin-1 (IL-1) receptor; when HMGB1 binds to the ligand
    (for example, lipopolysaccharide or IL-1) this augments subsequent proinflammatory
    signaling. Therefore, dexmedetomidine acts proximally in the pathway (at the cytoprotective
    level) to prevent the elaboration of renal ischemic injury. 'Lightening bolt'
    denotes ischemia. 'Square' denotes HMGB1 co-receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - de
  - Toll-4
  - SCGB2A2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TLR4
---
